List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 63 studies with search of: "Rabeprazole"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Condition: Refractory Reflux Esophagitis
Intervention: Drug: E3810
2 Recruiting Compare How Effective Standard Dose Proton Pump Inhibitor (PPI) and Low Dose Tricyclic Antidepressant and Double Dose PPI to Standard Dose PPI and Placebo
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: Rabeprazole 20mg, placebo dinner and bedtime;   Drug: Rabeprazole 20 mg two times, Placebo at bedtime;   Drug: Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant
3 Recruiting Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
Conditions: Early Gastric Adenocarcinoma;   Adenocarcinoma, Tubular
Interventions: Drug: rabeprazole;   Drug: placebo
4 Active, not recruiting Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Condition: Symptomatic Gastroesophageal Reflux Disease (sGERD)
Interventions: Drug: rabeprazole sodium (Aciphex);   Drug: Placebo
5 Completed
Has Results 		E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Condition: Heartburn
Interventions: Drug: rabeprazole sodium;   Drug: placebo
6 Recruiting To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)
Condition: Gastroesophageal Reflux
Interventions: Drug: Rabeprazole sodium capsules;   Drug: placebo
7 Active, not recruiting Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: omeprazole sodium IV;   Drug: Rabeprazole
8 Recruiting Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel
9 Recruiting A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients.
Conditions: GERD;   Gastroesophageal Reflux Disease
Intervention: Drug: rabeprazole
10 Recruiting Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding
Condition: Nonvariceal Upper Gastrointestinal Bleeding
Interventions: Drug: Intravenous Omeprazole;   Drug: Oral Rabeprazole
11 Completed
Has Results 		E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Condition: Heartburn
Interventions: Drug: rabeprazole sodium;   Other: Placebo
12 Completed Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Tablets 20 mg;   Drug: Aciphex® Tablets 20 mg
13 Completed Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Delayed-Release Tablets 20 mg;   Drug: Aciphex® Tablets 20 mg
14 Completed Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Delayed-Release Tablets 20 mg;   Drug: Aciphex® Delayed-Release Tablets 20 mg
15 Active, not recruiting Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
16 Recruiting Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
17 Active, not recruiting Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
18 Recruiting A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD).
Condition: Gastroesophageal Reflux
Intervention: Drug: Rabeprazole sodium
19 Completed A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn
Condition: Gastroesophageal Reflux
Intervention: Drug: rabeprazole and pantoprazole
20 Completed Rabeprazole Protection of Aspirin Induced Gastric Damage.
Condition: Normal Subjects
Intervention: Drug: Rabeprazole

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services